Atlas Trials

A Study of Everolimus in Combination With Imatinib in Metastatic Melanoma

Clinical trial NCT00402662 · TERMINATED

Trial details

NCT number
NCT00402662
Sponsor
Yale University
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic Melanoma
Start date
2006-02-01
Primary completion
2006-06-01
Enrollment
3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.